ADC Therapeutics SA (ADCT)
Data as of , from SEC Form 4 filings.
See up to 3 months of ADCT. The 7-day demo opens the 1M and 3M ranges and puts ADCT on your watchlist.
Start 7-day demoLatest ADCT insider trades
About ADC Therapeutics SA (ADCT)
The SEC lists ADC Therapeutics SA under CIK 0001771910, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ADCT Form 4 activity by transaction type, last 90 days
No Form 4 activity for ADCT in the last 90 days.
ADCT insider transactions (Form 4)
5225 Form 4 filings on record, the earliest from Dec 6, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mohamed Zaki - Officer | Grant or award | Common Shares | 213,900 footnote F1 | $0.00 | - | |
| ||||||
| Peter J. Graham - Officer | Grant or award | Common Shares | 221,100 footnote F1 | $0.00 | - | |
| ||||||
| Jose Carmona - Officer | Grant or award | Common Shares | 203,700 footnote F1 | $0.00 | - | |
| ||||||
| Ameet Mallik - Officer | Grant or award | Common Shares | 675,000 footnote F1 | $0.00 | - | |
| ||||||
| Robert Azelby - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| Robert Azelby - Director | Tax withholding / forfeiture | Common Shares | 12,600 | $3.08 | $39K | |
| ||||||
| Ron Squarer - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| Ron Squarer - Director | Tax withholding / forfeiture | Common Shares | 15,196 | $3.08 | $47K | |
| ||||||
| Victor Sandor - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| Victor Sandor - Director | Tax withholding / forfeiture | Common Shares | 12,600 | $3.08 | $39K | |
| ||||||
| Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Shares | 2,596 | $3.08 | $8K | ||
| ||||||
| Peter Hug - Director | Tax withholding / forfeiture | Common Shares | 2,156 | $3.08 | $7K | |
| Peter Hug - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| ||||||
| Jean-Pierre Bizzari - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| Jean-Pierre Bizzari - Director | Tax withholding / forfeiture | Common Shares | 12,600 | $3.08 | $39K | |
| ||||||
| Timothy Coughlin - Director | Grant or award | Common Shares | 45,000 footnote F1 | $0.00 | - | |
| Timothy Coughlin - Director | Tax withholding / forfeiture | Common Shares | 12,600 | $3.08 | $39K | |
| ||||||
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 196,229 | $3.75 footnote F3 | $736K | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 188,407 | $3.75 footnote F3 | $707K | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 169,265 | $3.80 footnote F4 | $643K | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 162,517 | $3.80 footnote F4 | $617K | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 2,634,506 | $3.28 footnote F5 | $8.64M | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Stock | 2,529,491 | $3.28 footnote F5 | $8.29M | |
| ||||||
| Lisa Michelle Kallebo - Officer | Grant or award | Common Shares | 62,900 footnote F1 | $3.99 | $251K | |
| Lisa Michelle Kallebo - Officer | Tax withholding / forfeiture | Common Shares | 5,433 footnote F2 | $3.99 | $22K | |
| ||||||
| Mohamed Zaki - Officer | Grant or award | Common Shares | 285,200 footnote F1 | $3.99 | $1.14M | |
| Mohamed Zaki - Officer | Tax withholding / forfeiture | Common Shares | 24,603 footnote F2 | $3.99 | $98K | |
| ||||||
| Peter J. Graham - Officer | Grant or award | Common Shares | 294,800 footnote F1 | $3.99 | $1.18M | |
| Peter J. Graham - Officer | Tax withholding / forfeiture | Common Shares | 33,294 footnote F2 | $3.99 | $133K | |
| ||||||
| Jose Carmona - Officer | Grant or award | Common Shares | 271,600 footnote F1 | $3.99 | $1.08M | |
| Jose Carmona - Officer | Tax withholding / forfeiture | Common Shares | 25,880 footnote F2 | $3.99 | $103K | |
| ||||||
| Ameet Mallik - Officer | Grant or award | Common Shares | 900,000 footnote F1 | $3.99 | $3.59M | |
| Ameet Mallik - Officer | Tax withholding / forfeiture | Common Shares | 103,231 footnote F3 | $3.99 | $412K | |
| ||||||
| Redmile Group, LLC - 10% Owner | Open-market purchase | Pre-Funded Warrants | 3,846,153 | $3.90 | $15.00M | |
| Redmile Group, LLC - 10% Owner | Open-market purchase | Pre-Funded Warrants | 3,846,153 | $3.90 | $15.00M | |
| Redmile Group, LLC - 10% Owner | Open-market purchase | Common Shares, par value CHF 0.08 per share | 50,000 | $2.28 | $114K | |
| Redmile Group, LLC - 10% Owner | Open-market purchase | Common Shares, par value CHF 0.08 per share | 50,000 | $3.81 | $191K | |
| Redmile Group, LLC - 10% Owner | Open-market purchase | Common Shares, par value CHF 0.08 per share | 50,000 | $2.28 | $114K | |
| Redmile Group, LLC - 10% Owner | Open-market purchase | Common Shares, par value CHF 0.08 per share | 50,000 | $3.81 | $191K | |
| Mohamed Zaki - Officer | Tax withholding / forfeiture | Common Shares | 37,112 | $3.13 | $116K | |
| Lisa Michelle Kallebo - Officer | Tax withholding / forfeiture | Common Shares | 6,503 | $3.13 | $20K | |
| Ameet Mallik - Officer | Tax withholding / forfeiture | Common Shares | 238,343 | $3.13 | $746K | |
| Jose Carmona - Officer | Tax withholding / forfeiture | Common Shares | 48,108 | $3.13 | $151K | |
| Peter J. Graham - Officer | Tax withholding / forfeiture | Common Shares | 41,458 | $3.13 | $130K | |
| Redmile Group, LLC - 10% Owner | Open-market sale | Common Shares, par value CHF 0.08 per share | 25,352 | $2.07 | $52K | |
| Redmile Group, LLC - 10% Owner | Other | Common Shares, par value CHF 0.08 per share | 50,672 | $2.07 | $105K | |
| Redmile Group, LLC - 10% Owner | Other | Common Shares, par value CHF 0.08 per share | 50,672 | $2.07 | $105K | |
| Redmile Group, LLC - 10% Owner | Other | Common Shares, par value CHF 0.08 per share | 50,672 | $2.07 | $105K | |
| Redmile Group, LLC - 10% Owner | Other | Pre-Funded Warrants | 26,656 | $2.07 | $55K | |
| Redmile Group, LLC - 10% Owner | Other | Pre-Funded Warrants | 26,656 | $2.07 | $55K | |
| Redmile Group, LLC - 10% Owner | Other | Pre-Funded Warrants | 26,656 | $2.07 | $55K | |
ADCT insider trading FAQ
What is the latest insider trade for ADCT?
ADC Therapeutics SA (ADCT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-02. The full record for ADCT runs to 25 Form 4 filings, the earliest from 2024-12-06. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ADCT stock?
No insider purchases of ADCT were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling ADCT stock?
No insider sales of ADCT were filed in the last 90 days. 7 sales are on record for this company.
Where can I see ADCT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ADCT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mohamed Zaki view on EDGAR
- - Peter J. Graham view on EDGAR
- - Jose Carmona view on EDGAR
- - Ameet Mallik view on EDGAR
- - Robert Azelby view on EDGAR
- - Ron Squarer view on EDGAR
- - Victor Sandor view on EDGAR
- - Viviane Monges view on EDGAR
- - Peter Hug view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ADCT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ADCT with a 7-day demo
- ADCT on your watchlist
- Every ADCT Form 4 filing on record
- Up to 3 months of ADCT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive